07:23 AM EDT, 03/25/2026 (MT Newswires) -- ADMA Biologics ( ADMA ) said Wednesday that a short seller report issued by Culper Research contains "misleading, false, and inaccurate" statements.

The company said the report appeared to rely on speculative claims from unidentified sources.

ADMA said it is reviewing the assertions.

Shares of the company were up 2.7% pre-bell Wednesday, following a 16.6% drop in the previous session.